美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

MetaVia Inc

1.54

-0.0400-2.53%

盤後：1.52-0.0184-1.19%17:20 EDT

成交量：4.57萬

成交額：7.09萬

市值：1,014.57萬

市盈率：-0.41

高：1.59

開：1.57

低：1.52

收：1.58

52周最高：14.85

52周最低：0.9661

股本：658.81萬

流通股本：480.52萬

量比：0.25

換手率：0.95%

股息：- -

股息率：- -

每股收益(TTM):-3.7193

每股收益(LYR):-7.3500

淨資產收益率：-175.68%

總資產收益率：-58.82%

市淨率：1.49

市盈率(LYR):-0.21

資料載入中...

總覽公司新聞資訊公告

MetaVia Inc宣佈完成Da-1726治療肥胖症1期第3部分研究的劑量滴定

MetaVia股東批准反向股票分割，比例介於1比5至1比22之間

MetaVia在EASL 2026大會上公布DA-1726更高劑量一期結果，支持其在肥胖與MASH領域的潛力

BUZZ-MetaVia 因開始更高劑量肥胖症藥物研究而上漲

Metavia啓動Da-1726高劑量一期臨床研究首位肥胖症患者接受GLP-1/胰高血糖素雙激動劑給藥

BUZZ-MetaVia 因獲監管機構批准開始早期肥胖症試驗而上漲

MetaVia獲IRB批准推進DA-1726高劑量一期試驗 GLP-1/胰高血糖素雙激動劑展現最佳減重與血糖控制潛力

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/MTVA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","market":"US","secType":"STK","nameCN":"MetaVia Inc","latestPrice":1.54,"timestamp":1789588800000,"preClose":1.58,"halted":0,"volume":45733,"hourTrading":{"tag":"盘后","latestPrice":1.5216,"preClose":1.54,"latestTime":"17:20 EDT","volume":326,"amount":496.6343984,"timestamp":1789593639451,"change":-0.0184,"changeRate":-0.011948,"amplitude":0.044416},"delay":0,"changeRate":-0.025316455696202552,"floatShares":4805200,"shares":6588099,"eps":-3.71934,"marketStatus":"盤後交易","change":-0.04,"latestTime":"09-16 17:53:57 EDT","open":1.5701,"high":1.5901,"low":1.52,"amount":70948.97342210001,"amplitude":0.044367,"askPrice":1.59,"askSize":100,"bidPrice":1.5,"bidSize":9,"shortable":3,"etf":0,"ttmEps":-3.71934,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"listingDate":1470369600000,"exchange":"NASDAQ","adjPreClose":1.58,"preHourTrading":{"tag":"盘前","latestPrice":1.5958,"preClose":1.58,"latestTime":"09:24 EDT","volume":1471,"amount":2407.1060069,"timestamp":1789565076984,"change":0.0158,"changeRate":0.01,"amplitude":0.054747},"postHourTrading":{"tag":"盘后","latestPrice":1.5216,"preClose":1.54,"latestTime":"17:20 EDT","volume":326,"amount":496.6343984,"timestamp":1789593639451,"change":-0.0184,"changeRate":-0.011948,"amplitude":0.044416},"volumeRatio":0.253423},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTVA\",,,,,undefined,":{"symbol":"MTVA","floatShares":4805200,"roa":"-58.82%","roe":"-175.68%","lyrEps":-7.349999,"volumeRatio":0.253423,"shares":6588099,"dividePrice":0,"high":1.5901,"amplitude":0.044367,"preClose":1.58,"low":1.52,"week52Low":0.9661,"pbRate":"1.49","week52High":14.85,"institutionHeld":0,"latestPrice":1.54,"committee":-0.834862,"eps":-3.71934,"divideRate":0,"volume":45733,"delay":0,"ttmEps":-3.71934,"open":1.5701,"prevYearClose":8.42,"prevWeekClose":1.66,"prevMonthClose":1.72,"prevQuarterClose":1.43,"fiveDayClose":1.74,"twentyDayClose":1.49,"sixtyDayClose":1.57},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"MTVA","fiscalQuarterEnding":"2026/06","expectedEps":-0.85,"name":null,"time":"盤後","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.9},{"market":"US","date":"2026-05-14","symbol":"MTVA","fiscalQuarterEnding":"2026/03","expectedEps":-0.76,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778731200000,"reportTimeType":"post","actualEps":-0.79},{"date":"2026-03-26","symbol":"MTVA","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":-2.06,"defaultRemindTime":1774512000000,"name":null,"time":"盤前","dateTimestamp":1774497600000,"actualEps":null},{"market":"US","date":"2025-12-05","symbol":"MTVA","defaultRemindTime":1764945000000,"type":"split","dateTimestamp":1764910800000,"forFactor":11,"toFactor":1,"ratio":11},{"market":"US","date":"2025-11-06","symbol":"MTVA","fiscalQuarterEnding":"2025/09","expectedEps":-0.26,"name":null,"time":"盤前","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-0.14}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTVA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1735617600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTVA","date":"2026-09-15","current":-0.415396,"percent":0.32809,"low":-1.962939,"twenty":-1.011233,"median":-0.585732,"eighty":-0.466986,"high":-0.203888,"avg":-0.69191,"sd":0.326082,"marketCap":10672723},"quantilePoints":[{"date":"2024-12-06","current":-0.714557,"twenty":-0.800304,"median":-0.792227,"eighty":-0.751814,"marketCap":19816823},{"date":"2024-12-13","current":-0.716111,"twenty":-0.79347,"median":-0.728538,"eighty":-0.7158,"marketCap":19859903},{"date":"2024-12-20","current":-0.546792,"twenty":-0.767348,"median":-0.716111,"eighty":-0.685354,"marketCap":15164177},{"date":"2024-12-27","current":-0.562326,"twenty":-0.746234,"median":-0.70213,"eighty":-0.556112,"marketCap":15594978},{"date":"2025-01-03","current":-0.655529,"twenty":-0.730091,"median":-0.686597,"eighty":-0.553006,"marketCap":18179781},{"date":"2025-01-10","current":-0.661742,"twenty":-0.733198,"median":-0.686597,"eighty":-0.564811,"marketCap":18352101},{"date":"2025-01-17","current":-0.58718,"twenty":-0.720771,"median":-0.663296,"eighty":-0.577238,"marketCap":16284258},{"date":"2025-01-24","current":-0.602714,"twenty":-0.720771,"median":-0.647762,"eighty":-0.584073,"marketCap":16715059},{"date":"2025-01-31","current":-0.584073,"twenty":-0.717664,"median":-0.630675,"eighty":-0.584073,"marketCap":16198098},{"date":"2025-02-07","current":-0.562326,"twenty":-0.716111,"median":-0.615141,"eighty":-0.562326,"marketCap":15594978},{"date":"2025-02-14","current":-0.512617,"twenty":-0.714557,"median":-0.608927,"eighty":-0.546792,"marketCap":14216416},{"date":"2025-02-21","current":-0.509511,"twenty":-0.704615,"median":-0.602714,"eighty":-0.540578,"marketCap":14130256},{"date":"2025-02-28","current":-0.453589,"twenty":-0.699297,"median":-0.58718,"eighty":-0.518583,"marketCap":12579374},{"date":"2025-03-07","current":-0.487763,"twenty":-0.688995,"median":-0.584073,"eighty":-0.503297,"marketCap":13527135},{"date":"2025-03-14","current":-0.467569,"twenty":-0.681626,"median":-0.568539,"eighty":-0.495468,"marketCap":12967095},{"date":"2025-03-21","current":-0.48401,"twenty":-0.667956,"median":-0.562326,"eighty":-0.487763,"marketCap":13354815},{"date":"2025-03-28","current":-0.48933,"twenty":-0.662363,"median":-0.546792,"eighty":-0.487763,"marketCap":13501595},{"date":"2025-04-04","current":-0.47992,"twenty":-0.656772,"median":-0.540578,"eighty":-0.485083,"marketCap":13241949},{"date":"2025-04-11","current":-0.429732,"twenty":-0.643102,"median":-0.539025,"eighty":-0.482756,"marketCap":11857170},{"date":"2025-04-17","current":-0.23033,"twenty":-0.636267,"median":-0.537471,"eighty":-0.476844,"marketCap":6355270},{"date":"2025-04-25","current":-0.266622,"twenty":-0.631917,"median":-0.512617,"eighty":-0.463425,"marketCap":7356638},{"date":"2025-05-02","current":-0.239019,"twenty":-0.626947,"median":-0.506404,"eighty":-0.454331,"marketCap":6595010},{"date":"2025-05-09","current":-0.222708,"twenty":-0.618869,"median":-0.49874,"eighty":-0.452346,"marketCap":6144956},{"date":"2025-05-16","current":-0.238257,"twenty":-0.615141,"median":-0.497083,"eighty":-0.429105,"marketCap":5848960},{"date":"2025-05-23","current":-0.285534,"twenty":-0.611413,"median":-0.49458,"eighty":-0.263184,"marketCap":7009578},{"date":"2025-05-30","current":-0.543676,"twenty":-0.612655,"median":-0.49689,"eighty":-0.271352,"marketCap":13346706},{"date":"2025-06-06","current":-0.549972,"twenty":-0.608927,"median":-0.497673,"eighty":-0.281282,"marketCap":13501264},{"date":"2025-06-13","current":-0.597709,"twenty":-0.608927,"median":-0.503297,"eighty":-0.294785,"marketCap":14673160},{"date":"2025-06-20","current":-0.557862,"twenty":-0.607995,"median":-0.509511,"eighty":-0.332562,"marketCap":13694949},{"date":"2025-06-27","current":-0.542591,"twenty":-0.603956,"median":-0.515396,"eighty":-0.428478,"marketCap":13320078},{"date":"2025-07-03","current":-0.516978,"twenty":-0.602714,"median":-0.515103,"eighty":-0.429732,"marketCap":12691292},{"date":"2025-07-11","current":-0.572913,"twenty":-0.599701,"median":-0.516978,"eighty":-0.432869,"marketCap":14064436},{"date":"2025-07-18","current":-0.535431,"twenty":-0.597709,"median":-0.518414,"eighty":-0.439456,"marketCap":13144307},{"date":"2025-07-25","current":-0.587857,"twenty":-0.5965,"median":-0.521601,"eighty":-0.450482,"marketCap":14431313},{"date":"2025-08-01","current":-0.482926,"twenty":-0.587857,"median":-0.520838,"eighty":-0.453589,"marketCap":11855342},{"date":"2025-08-08","current":-0.674088,"twenty":-0.587857,"median":-0.518654,"eighty":-0.453589,"marketCap":12464564},{"date":"2025-08-15","current":-0.837521,"twenty":-0.602714,"median":-0.525504,"eighty":-0.453589,"marketCap":15486597},{"date":"2025-08-22","current":-0.836212,"twenty":-0.615141,"median":-0.534692,"eighty":-0.453589,"marketCap":15462399},{"date":"2025-08-29","current":-0.846681,"twenty":-0.624461,"median":-0.53558,"eighty":-0.454826,"marketCap":15655982},{"date":"2025-09-05","current":-0.898895,"twenty":-0.643102,"median":-0.537471,"eighty":-0.457336,"marketCap":16621475},{"date":"2025-09-12","current":-0.894708,"twenty":-0.675347,"median":-0.537746,"eighty":-0.459434,"marketCap":16544042},{"date":"2025-09-19","current":-1.200403,"twenty":-0.704615,"median":-0.540578,"eighty":-0.459802,"marketCap":22196650},{"date":"2025-09-26","current":-1.308626,"twenty":-0.720771,"median":-0.542033,"eighty":-0.464632,"marketCap":24197809},{"date":"2025-10-03","current":-1.285464,"twenty":-0.777314,"median":-0.543184,"eighty":-0.467223,"marketCap":23769507},{"date":"2025-10-10","current":-1.347885,"twenty":-0.814044,"median":-0.546792,"eighty":-0.468812,"marketCap":24923743},{"date":"2025-10-17","current":-1.360971,"twenty":-0.829721,"median":-0.548697,"eighty":-0.471608,"marketCap":25165721},{"date":"2025-10-24","current":-1.257721,"twenty":-0.836474,"median":-0.551486,"eighty":-0.475169,"marketCap":23256514},{"date":"2025-10-31","current":-1.275649,"twenty":-0.839353,"median":-0.556987,"eighty":-0.478202,"marketCap":23588024},{"date":"2025-11-07","current":-1.112332,"twenty":-0.856339,"median":-0.562326,"eighty":-0.479691,"marketCap":20568137},{"date":"2025-11-14","current":-0.985555,"twenty":-0.895545,"median":-0.562464,"eighty":-0.481224,"marketCap":15981760},{"date":"2025-11-21","current":-0.990035,"twenty":-0.925649,"median":-0.572913,"eighty":-0.482587,"marketCap":16054404},{"date":"2025-11-28","current":-1.16176,"twenty":-1.03994,"median":-0.573323,"eighty":-0.482894,"marketCap":18839105},{"date":"2025-12-05","current":-0.993021,"twenty":-1.048481,"median":-0.575956,"eighty":-0.483005,"marketCap":16102829},{"date":"2025-12-12","current":-1.162032,"twenty":-1.114901,"median":-0.581053,"eighty":-0.483057,"marketCap":18843504},{"date":"2025-12-19","current":-1.126736,"twenty":-1.121412,"median":-0.584073,"eighty":-0.483629,"marketCap":18271155},{"date":"2025-12-26","current":-1.324933,"twenty":-1.135751,"median":-0.58567,"eighty":-0.484268,"marketCap":21485117},{"date":"2026-01-02","current":-1.143026,"twenty":-1.158344,"median":-0.587519,"eighty":-0.484763,"marketCap":18535316},{"date":"2026-01-09","current":-1.138004,"twenty":-1.161978,"median":-0.597709,"eighty":-0.485344,"marketCap":18453866},{"date":"2026-01-16","current":-0.447979,"twenty":-1.16176,"median":-0.601208,"eighty":-0.485344,"marketCap":7264435},{"date":"2026-01-23","current":-0.551981,"twenty":-1.16176,"median":-0.598705,"eighty":-0.485958,"marketCap":8950917},{"date":"2026-01-30","current":-0.466908,"twenty":-1.144681,"median":-0.593528,"eighty":-0.48519,"marketCap":7571385},{"date":"2026-02-06","current":-0.342268,"twenty":-1.143026,"median":-0.58718,"eighty":-0.483057,"marketCap":5550210},{"date":"2026-02-13","current":-0.328419,"twenty":-1.140855,"median":-0.584073,"eighty":-0.480757,"marketCap":5325635},{"date":"2026-02-20","current":-0.308634,"twenty":-1.138574,"median":-0.583444,"eighty":-0.475169,"marketCap":5004813},{"date":"2026-02-27","current":-0.31457,"twenty":-1.130076,"median":-0.57751,"eighty":-0.466694,"marketCap":5101060},{"date":"2026-03-06","current":-0.31457,"twenty":-1.127008,"median":-0.573733,"eighty":-0.459434,"marketCap":5101060},{"date":"2026-03-13","current":-0.318526,"twenty":-1.122978,"median":-0.572913,"eighty":-0.453589,"marketCap":5165224},{"date":"2026-03-20","current":-0.292807,"twenty":-1.121203,"median":-0.56645,"eighty":-0.449981,"marketCap":4748156},{"date":"2026-03-27","current":-0.359359,"twenty":-1.119202,"median":-0.562326,"eighty":-0.429418,"marketCap":4661961},{"date":"2026-04-02","current":-0.490532,"twenty":-1.117842,"median":-0.56111,"eighty":-0.431614,"marketCap":6363670},{"date":"2026-04-10","current":-0.466986,"twenty":-1.114293,"median":-0.557862,"eighty":-0.436821,"marketCap":6058213},{"date":"2026-04-17","current":-0.549396,"twenty":-1.111355,"median":-0.557553,"eighty":-0.44457,"marketCap":7127310},{"date":"2026-04-24","current":-0.605091,"twenty":-1.10949,"median":-0.558572,"eighty":-0.449481,"marketCap":7849842},{"date":"2026-05-01","current":-0.573244,"twenty":-1.107704,"median":-0.562326,"eighty":-0.452346,"marketCap":7436692},{"date":"2026-05-08","current":-0.529454,"twenty":-1.10583,"median":-0.562326,"eighty":-0.453589,"marketCap":6868612},{"date":"2026-05-15","current":-0.473722,"twenty":-1.101758,"median":-0.559233,"eighty":-0.449481,"marketCap":6145600},{"date":"2026-05-22","current":-1.129276,"twenty":-1.10583,"median":-0.559894,"eighty":-0.44457,"marketCap":14821741},{"date":"2026-05-29","current":-1.219775,"twenty":-1.111681,"median":-0.562326,"eighty":-0.44898,"marketCap":16009547},{"date":"2026-06-05","current":-0.964016,"twenty":-1.111681,"median":-0.563942,"eighty":-0.451725,"marketCap":12652706},{"date":"2026-06-12","current":-0.790886,"twenty":-1.109895,"median":-0.569786,"eighty":-0.453589,"marketCap":10380383},{"date":"2026-06-18","current":-0.672844,"twenty":-1.108355,"median":-0.572913,"eighty":-0.453589,"marketCap":8831072},{"date":"2026-06-26","current":-0.602018,"twenty":-1.106645,"median":-0.573284,"eighty":-0.453589,"marketCap":7901486},{"date":"2026-07-02","current":-0.57054,"twenty":-1.105016,"median":-0.573244,"eighty":-0.453589,"marketCap":7488336},{"date":"2026-07-10","current":-0.680713,"twenty":-1.099586,"median":-0.573733,"eighty":-0.454826,"marketCap":8934360},{"date":"2026-07-17","current":-0.708256,"twenty":-1.074189,"median":-0.57751,"eighty":-0.457016,"marketCap":9295866},{"date":"2026-07-24","current":-0.594148,"twenty":-1.066319,"median":-0.582344,"eighty":-0.457963,"marketCap":7798198},{"date":"2026-07-31","current":-0.566605,"twenty":-1.0655,"median":-0.57786,"eighty":-0.458903,"marketCap":7436692},{"date":"2026-08-07","current":-0.57054,"twenty":-1.056933,"median":-0.57751,"eighty":-0.459669,"marketCap":7488336},{"date":"2026-08-14","current":-0.665833,"twenty":-1.054581,"median":-0.577159,"eighty":-0.459802,"marketCap":9618627},{"date":"2026-08-21","current":-0.656712,"twenty":-1.052561,"median":-0.581699,"eighty":-0.462321,"marketCap":9486865},{"date":"2026-08-28","current":-0.757043,"twenty":-1.045807,"median":-0.583444,"eighty":-0.465262,"marketCap":10936247},{"date":"2026-09-04","current":-0.839132,"twenty":-1.038506,"median":-0.584117,"eighty":-0.466694,"marketCap":12122105},{"date":"2026-09-11","current":-0.798088,"twenty":-1.021569,"median":-0.58495,"eighty":-0.466955,"marketCap":11529176},{"date":"2026-09-15","current":-0.738801,"twenty":-1.011233,"median":-0.585732,"eighty":-0.466986,"marketCap":10672723}],"updateTime":1789579915418},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTVA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1125748257","title":"MetaVia Inc宣佈完成Da-1726治療肥胖症1期第3部分研究的劑量滴定","url":"https://stock-news.laohu8.com/highlight/detail?id=1125748257","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125748257?lang=zh_tw&edition=fundamental","pubTime":"2026-07-09 20:31","pubTimestamp":1783600310,"startTime":"0","endTime":"0","summary":"MetaVia Inc宣布，其用于治疗肥胖症的药物Da-1726，在1期临床试验的第3部分研究中，已成功完成剂量滴定阶段。这一进展标志着该药物研发过程中的一个重要里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144525325","title":"MetaVia股東批准反向股票分割，比例介於1比5至1比22之間","url":"https://stock-news.laohu8.com/highlight/detail?id=1144525325","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144525325?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 04:05","pubTimestamp":1780949115,"startTime":"0","endTime":"0","summary":"根据提交给美国证券交易委员会的文件，MetaVia Inc的股东已批准一项反向股票分割计划，具体执行比例将在1比5至1比22的范围内确定。\n该反向分割的最终比例将由公司董事会酌情决定，旨在提升每股股价，并可能满足相关证券交易所的持续上市要求。这一举措通常被股价长期低于规定门槛的公司所采用。\n股东授权董事会在此范围内实施反向分割，无需进一步征得股东同意。公司预计将在确定具体比例与生效日期后发布进一步公告。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171139494","title":"MetaVia在EASL 2026大會上公布DA-1726更高劑量一期結果，支持其在肥胖與MASH領域的潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1171139494","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171139494?lang=zh_tw&edition=fundamental","pubTime":"2026-05-27 20:31","pubTimestamp":1779885096,"startTime":"0","endTime":"0","summary":"MetaVia公司在2026年欧洲肝脏研究学会（EASL）大会上，公布了其候选药物DA-1726更高剂量组的一期临床试验结果。新数据进一步支持了该药物在治疗肥胖及代谢相关脂肪性肝炎（MASH）方面的潜在应用价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626190491","title":"BUZZ-MetaVia 因開始更高劑量肥胖症藥物研究而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2626190491","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626190491?lang=zh_tw&edition=fundamental","pubTime":"2026-04-10 20:44","pubTimestamp":1775825085,"startTime":"0","endTime":"0","summary":"** 补充说，DA-1726针对两种食欲和能量控制激素，每周注射一次** 预计 2026 年第四季度出结果** 截至上一交易日收盘，股价年跌幅约为 1%(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nL4T40T0YQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108786766","title":"Metavia啓動Da-1726高劑量一期臨床研究 首位肥胖症患者接受GLP-1/胰高血糖素雙激動劑給藥","url":"https://stock-news.laohu8.com/highlight/detail?id=1108786766","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108786766?lang=zh_tw&edition=fundamental","pubTime":"2026-04-10 20:30","pubTimestamp":1775824246,"startTime":"0","endTime":"0","summary":"生物制药公司Metavia近日宣布，其针对肥胖症治疗的GLP-1与胰高血糖素双靶点激动剂Da-1726已完成高剂量组一期临床试验的首例患者给药。该研究旨在评估药物在提升剂量水平下的安全性与耐受性，标志着这款代谢疾病疗法开发取得重要阶段性进展。Da-1726通过同时激活GLP-1和胰高血糖素受体，有望在控制血糖的同时增强能量消耗，为肥胖治疗提供新机制方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620025544","title":"BUZZ-MetaVia 因獲監管機構批准開始早期肥胖症試驗而上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2620025544","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620025544?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 20:42","pubTimestamp":1773837720,"startTime":"0","endTime":"0","summary":"** 迈阿密临床药理学机构审查委员会的批准允许该公司开始招收早期试验下一部分的参与者，该试验旨在通过两种不同的滴定方案评估更高的药物剂量。** MetaVia公司表示，早期试验的第三部分将招募40名健康的肥胖症成人患者。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nL4S406146:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MTVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187742668","title":"MetaVia獲IRB批准推進DA-1726高劑量一期試驗 GLP-1/胰高血糖素雙激動劑展現最佳減重與血糖控制潛力","url":"https://stock-news.laohu8.com/highlight/detail?id=1187742668","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187742668?lang=zh_tw&edition=fundamental","pubTime":"2026-03-18 20:03","pubTimestamp":1773835407,"startTime":"0","endTime":"0","summary":"MetaVia Inc宣布，其核心肥胖治疗项目DA-1726获得机构审查委员会批准，将开展更高剂量的第一阶段临床试验。DA-1726是一种GLP-1与胰高血糖素双受体激动剂，临床前数据显示其在减重和血糖控制方面具备同类最佳潜力。DA-1726通过同时激活GLP-1和胰高血糖素受体，模拟肠道激素的自然作用。MetaVia计划在本季度内启动高剂量组的一期临床试验，重点评估DA-1726在健康受试者中的安全性、耐受性及药代动力学特征。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTVA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":7,"code":"91000000","status":"200"}]}}